New Liberty Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 20-12-2024
- Paid Up Capital ₹ 1.50 M
as on 20-12-2024
- Company Age 7 Months 24 Days
About New Liberty Diagnostics
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sundaravadhanam Venkatesh, Hema Venkatesh, Vijay Maheshwaran, and Three other members serve as directors at the Company.
- CIN/LLPIN
U86905TN2024PTC169869
- Company No.
169869
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at New Liberty Diagnostics?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sundaravadhanam Venkatesh  | Director | 30-Apr-2024 | Current |
| Hema Venkatesh | Director | 30-Apr-2024 | Current |
| Vijay Maheshwaran | Director | 30-Apr-2024 | Current |
| Satheesh Laxman | Director | 30-Apr-2024 | Current |
| Sarath Pillai | Director | 30-Apr-2024 | Current |
| Alagappan Vinoth | Director | 30-Apr-2024 | Current |
Financial Performance of New Liberty Diagnostics.
Enhance accessibility to New Liberty Diagnostics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of New Liberty Diagnostics?
Unlock access to New Liberty Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Liberty High Scans Private LimitedActive 17 years 3 daysSundaravadhanam Venkatesh is a mutual person
- Anjaneya Printers Private LimitedActive 31 years 5 months
Sundaravadhanam Venkatesh is a mutual person
- Sastry Nuts Plates Manufacturers Private LimitedActive 37 years 6 months
Sundaravadhanam Venkatesh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at New Liberty Diagnostics?
New Liberty Diagnostics has a workforce of 0 employees as of May 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Liberty Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Liberty Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.